FDG PET/CT in carcinoma of unknown primary

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 3, 2010, Pages 635-644

  Kwee, Thomas C ^a   Basu, Sandip ^b,c   Cheng, Gang ^b   Alavi, Abass ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

18F fluoro 2 deoxyglucose; Carcinoma of unknown primary; Computed tomography; FDG PET CT; Position emission tomography; Primary tumor detection

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER OF UNKNOWN PRIMARY SITE; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; GLUCOSE METABOLISM; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SIGNAL NOISE RATIO; WHOLE BODY CT; WHOLE BODY MRI; WHOLE BODY PET;

FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949275789     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1295-6     Document Type: Review

References (61)

1. N Pavlidis K Fizazi 2009 Carcinoma of unknown primary (CUP) Crit Rev Oncol Hematol 69 271 278 10.1016/j.critrevonc.2008.09.005 18977667
2. I Haas TK Hoffmann R Engers U Ganzer 2002 Diagnostic strategies in cervical carcinoma of an unknown primary (CUP) Eur Arch Otorhinolaryngol 259 325 323 10.1007/s004050100408 12115082 (Pubitemid 34437987)
3. MN Raber J Faintuch JL Abbruzzese C Sumrall P Frost 1991 Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin Ann Oncol 2 519 520 1:STN:280:DyaK38%2FgtFKhuw%3D%3D 1911461
4. S Rege A Maass L Chaiken CK Hoh Y Choi R Lufkin, et al. 1994 Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers Cancer 73 3047 3058 10.1002/1097- 0142(19940615)73:12<3047::AID-CNCR2820731225>3.0.CO;2-# 1:STN:280:DyaK2c3lvVKktg%3D%3D 8200003 (Pubitemid 24170781)
5. EM Rohren TG Turkington RE Coleman 2004 Clinical applications of PET in oncology Radiology 231 305 332 10.1148/radiol.2312021185 15044750 (Pubitemid 38552885)
6. JL Roh JS Kim JH Lee KJ Cho SH Choi SY Nam SY Kim 2009 Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors Oral Oncol 45 218 224 10.1016/j.oraloncology.2008.05.010 18804404
7. K Nassenstein P Veit-Haibach H Stergar A Gutzeit L Freudenberg H Kuehl, et al. 2007 Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography Acta Radiol 48 1101 1108 10.1080/02841850701581768 (Pubitemid 350196146)
8. LS Freudenberg M Fischer G Antoch W Jentzen A Gutzeit SJ Rosenbaum, et al. 2005 Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary Med Princ Pract 14 155 160 10.1159/000084632 15863988 (Pubitemid 40663292)
9. A Gutzeit G Antoch H Kühl T Egelhof M Fischer E Hauth, et al. 2005 Unknown primary tumors: detection with dual-modality PET/CT-initial experience Radiology 234 227 234 10.1148/radiol.2341031554 15564390 (Pubitemid 39662772)
10. O Mawlawi DW Townsend 2009 Multimodality imaging: an update on PET/CT technology Eur J Nucl Med Mol Imaging 36 Suppl 1 S15 S29 10.1007/s00259-008- 1016-6 19104808
11. V Kapoor BM McCook FS Torok 2004 An introduction to PET-CT imaging Radiographics 24 523 543 10.1148/rg.242025724 15026598
12. TC Kwee RM Kwee 2009 Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis Eur Radiol 19 731 744 10.1007/s00330-008-1194-4 18925401
13. TF Hany J Heuberger GK von Schulthess 2003 Iatrogenic FDG foci in the lungs: a pitfall of PET image interpretation Eur Radiol 13 2122 2127 10.1007/s00330-002-1681-y 12928963 (Pubitemid 37080747)
14. G El-Haddad A Alavi A Mavi G Bural H Zhuang 2004 Normal variants in [18F]-fluorodeoxyglucose PET imaging Radiol Clin North Am 42 1063 1081 10.1016/j.rcl.2004.07.003 15488558 (Pubitemid 39361460)
15. F Fischbach F Knollmann V Griesshaber T Freund E Akkol R Felix 2003 Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness Eur Radiol 13 2378 2383 10.1007/s00330-003-1915-7 12743736 (Pubitemid 37220375)
16. N Al-Brahim C Ross B Carter K Chorneyko 2005 The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center Ann Diagn Pathol 9 77 80 10.1016/j.anndiagpath.2004. 12.003 15806513 (Pubitemid 40460741)
17. H Blaszyk A Hartmann J Bjornsson 2003 Cancer of unknown primary: clinicopathologic correlations APMIS 111 1089 1094 10.1111/j.1600-0463.2003. apm1111203.x 14678017 (Pubitemid 38091247)
18. JI Mayordomo JM Guerra C Guijarro MD García-Prats A Gómez M López-Brea, et al. 1993 Neoplasms of unknown primary site: a clinicopathological study of autopsied patients Tumori 79 321 324 1:STN:280:DyaK2c7mtVektQ%3D%3D 8116074
19. T Le Chevalier E Cvitkovic P Caille J Harvey G Contesso M Spielmann, et al. 1988 Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients Arch Intern Med 148 2035 2039 10.1001/archinte.148.9.2035 3046543 (Pubitemid 18211044)
20. P Fencl O Belohlavek M Skopalova M Jaruskova I Kantorova K Simonova 2007 Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary Eur J Nucl Med Mol Imaging 34 1783 1792 10.1007/s00259-007-0456-8 17541584 (Pubitemid 47599050)
21. MR Ay H Zaidi 2006 Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET Eur J Nucl Med Mol Imaging 33 1301 1313 10.1007/s00259-006-0086-6 16622710 (Pubitemid 44630786)
22. S Namasivayam MK Kalra WE Torres WC Small 2006 Adverse reactions to intravenous iodinated contrast media: a primer for radiologists Emerg Radiol 12 210 215 10.1007/s10140-006-0488-6 16688432 (Pubitemid 44065552)
23. JD Hainsworth FA Greco 1993 Treatment of patients with cancer of an unknown primary site N Engl J Med 329 257 263 10.1056/NEJM199307223290407 1:STN:280:DyaK3szgt1yiuw%3D%3D 8316270 (Pubitemid 23203818)
24. MB Fukui TM Blodgett CH Snyderman JJ Johnson EN Myers DW Townsend, et al. 2005 Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging Radiographics 25 913 930 10.1148/rg.254045136 16009815
25. U Metser E Even-Sapir 2007 Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT Semin Nucl Med 37 206 222 10.1053/j.semnuclmed.2007.01. 001 17418153 (Pubitemid 46517465)
26. SS Shim KS Lee BT Kim JY Choi MJ Chung EJ Lee 2006 Focal parenchymal lung lesions showing a potential of false-positive and false-negative interpretations on integrated PET/CT AJR Am J Roentgenol 186 639 648 10.2214/AJR.04.1896 16498090 (Pubitemid 46100250)
27. C Wittram JA Scott 2007 18F-FDG PET of pulmonary embolism AJR Am J Roentgenol 189 171 176 10.2214/AJR.06.0640 17579168 (Pubitemid 46983208)
28. G Pentheroudakis E Briasoulis N Pavlidis 2007 Cancer of unknown primary site: missing primary or missing biology? Oncologist 12 418 425 10.1634/theoncologist.12-4-418 1:CAS:528:DC%2BD2sXmtlSitro%3D 17470684 (Pubitemid 46698719)
29. AJ van de Wouw RL Jansen EJ Speel HF Hillen 2003 The unknown biology of the unknown primary tumour: a literature review Ann Oncol 14 191 196 10.1093/annonc/mdg068 12562643 (Pubitemid 36305428)
30. P Sève C Billotey C Broussolle C Dumontet JR Mackey 2007 The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site Cancer 109 292 299 10.1002/cncr.22410 17167760 (Pubitemid 46116455)
31. KE Rusthoven M Koshy AC Paulino 2004 The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor Cancer 101 2641 2649 10.1002/cncr.20687 15517576 (Pubitemid 39532297)
32. RC Delgado-Bolton C Fernández-Pérez A González- Maté JL Carreras 2003 Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors J Nucl Med 44 1301 1314 12902422
33. JA Werner AA Dünne JN Myers 2003 Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma Head Neck 25 322 332 10.1002/hed.10257 12658737 (Pubitemid 36368684)
34. EL Rosen WB Eubank DA Mankoff 2007 FDG PET, PET/CT, and breast cancer imaging Radiographics 27 Suppl 1 S215 S229 10.1148/rg.27si075517 18180228
35. CL Buchanan EA Morris PL Dorn PI Borgen KJ Van Zee 2005 Utility of breast magnetic resonance imaging in patients with occult primary breast cancer Ann Surg Oncol 12 1045 1053 10.1245/ASO.2005.03.520 16244803 (Pubitemid 41660680)
36. C Schorn U Fischer S Luftner-Nagel JP Westerhof E Grabbe 1999 MRI of the breast in patients with metastatic disease of unknown primary Eur Radiol 9 470 473 10.1007/s003300050694 1:STN:280:DyaK1M7osleksw%3D%3D 10087118
37. AO Kaya U Coskun M Unlu UO Akdemir NY Ozdemir N Zengin, et al. 2008 Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin Asian Pac J Cancer Prev 9 683 686 19256759
38. GW Gladish DH Choe EM Marom BS Sabloff LD Broemeling RF Munden 2006 Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history Radiology 240 246 255 10.1148/radiol.2401051129 16684921
39. DV Schapira AR Jarrett 1995 The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma Arch Intern Med 155 2050 2054 10.1001/archinte.155.19.2050 1:STN:280: DyaK28%2FhtFGlsA%3D%3D 7575063
40. S Basu A Alavi 2007 FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies Eur J Nucl Med Mol Imaging 34 427 428 10.1007/s00259-006-0313-1 17195072 (Pubitemid 46295361)
41. JW Fletcher B Djulbegovic HP Soares BA Siegel VJ Lowe GH Lyman, et al. 2008 Recommendations on the use of 18F-FDG PET in oncology J Nucl Med 49 480 508 10.2967/jnumed.107.047787 18287273 (Pubitemid 351355215)
42. BE Hillner BA Siegel D Liu AF Shields IF Gareen L Hanna, et al. 2008 Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry J Clin Oncol 26 2155 2161 10.1200/JCO.2007.14.5631 18362365
43. C Bruna A Journo F Netter MC Kaminsky G Dolivet P Olivier, et al. 2007 On the interest of PET with 18F-FDG in the management of cancer of unknown primary (CUP) Med Nucl 31 242 249
44. M Wartski E Le Stanc E Gontier D Vilain A Banal C Tainturier, et al. 2007 In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT Nucl Med Commun 28 365 371 10.1097/MNM. 0b013e3280708edf 17414886 (Pubitemid 46569169)
45. N Fakhry M Barberet D Lussato S Cammilleri O Mundler A Giovanni, et al. 2006 Role of [18F]-FDG PET-CT in the management of the head and neck cancers Bull Cancer 93 1017 1025 1:CAS:528:DC%2BD2sXktVyjtg%3D%3D 17074660
46. E Pelosi M Pennone D Deandreis A Douroukas M Mancini G Bisi 2006 Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site Q J Nucl Med Mol Imaging 50 15 22 1:STN:280: DC%2BD287mvVSgtw%3D%3D 16557200
47. S Surti A Kuhn ME Werner AE Perkins J Kolthammer JS Karp 2007 Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities J Nucl Med 48 471 480 17332626
48. R Kumar H Dhanpathi S Basu D Rubello S Fanti A Alavi 2008 Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging Q J Nucl Med Mol Imaging 52 50 65 1:STN:280:DC%2BD1c%2Fnslyjtg%3D%3D 18235421
49. S Basu J Kung M Houseni H Zhuang GF Tidmarsh A Alavi 2009 Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions Q J Nucl Med Mol Imaging 53 9 19 1:STN:280:DC%2BD1M7hsFKjsA%3D%3D 18337683
50. S Sanz-Viedma DA Torigian M Parsons S Basu A Alavi 2009 Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging Rev Esp Med Nucl 28 159 166 10.1016/S0212-6982(09)71360-6 1:STN:280:DC%2BD1MvkvFalsw%3D%3D 19558958
51. Y Anzai S Minoshima GT Wolf RL Wahl 1999 Head and neck cancer: detection of recurrence with three-dimensional principal components analysis at dynamic FDG PET Radiology 212 285 290 1:STN:280:DyaK1MzjsVahtQ%3D%3D 10405755
52. S Pavlopoulos T Thireou G Kontaxakis A Santos 2007 Analysis and interpretation of dynamic FDG PET oncological studies using data reduction techniques Biomed Eng Online 6 36 10.1186/1475-925X-6-36 17915012 (Pubitemid 351234164)
53. T Thireou S Pavlopoulos G Kontaxakis A Santos 2006 Blind source separation for the computational analysis of dynamic oncological PET studies Oncol Rep 15 1007 1012 16525691
54. GK von Schulthess HP Schlemmer 2009 A look ahead: PET/MR versus PET/CT Eur J Nucl Med Mol Imaging 36 Suppl 1 S3 S9 10.1007/s00259-008-0940-9
55. G Antoch FM Vogt LS Freudenberg F Nazaradeh SC Goehde J Barkhausen, et al. 2003 Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology JAMA 290 3199 3206 10.1001/jama.290.24.3199 1:CAS:528:DC%2BD2cXjvVyr 14693872 (Pubitemid 38020681)
56. TC Kwee T Takahara R Ochiai K Katahira M Van Cauteren Y Imai, et al. 2009 Whole-body diffusion-weighted magnetic resonance imaging Eur J Radiol 70 409 417 10.1016/j.ejrad.2009.03.054 19403255
57. TC Kwee T Takahara R Ochiai RA Nievelstein PR Luijten 2008 Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology Eur Radiol 18 1937 1952 10.1007/s00330-008-0968-z 18446344
58. TF Gu XL Xiao F Sun JH Yin H Zhao 2008 Diagnostic value of whole body diffusion weighted imaging for screening primary tumors of patients with metastases Chin Med Sci J 23 145 150 10.1016/S1001-9294(09)60029-8 18853848
59. T Mori H Nomori K Ikeda K Kawanaka S Shiraishi K Katahira, et al. 2008 Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography J Thorac Oncol 3 358 364 10.1097/JTO.0b013e318168d9ed 18379353
60. GR Varadhachary D Talantov MN Raber C Meng KR Hess T Jatkoe, et al. 2008 Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation J Clin Oncol 26 4442 4448 10.1200/JCO.2007.14.4378 1:CAS:528:DC%2BD1cXht1ejur%2FF 18802157
61. HM Horlings RK van Laar JM Kerst HH Helgason J Wesseling JJ van der Hoeven, et al. 2008 Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary J Clin Oncol 26 4435 4441 10.1200/JCO.2007.14.6969 1:CAS:528:DC%2BD1cXht1ejur%2FL 18802156